Chiasma: Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings
The Company's annual report for the 12 months ended 31 December 2020, will be posted to shareholders in the coming days, along with a notice of general meeting.
Read full article »
Chiasma is engaged in developing and commercializing novel oral formulations of therapies to treat chronic diseases.
Read more